Omero P Costa Filho

GI oncology Surgeon focus on @hpb_surgery.

[BJS @BJSurgery]

Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi study
➡️https://t.co/HcqBIgv8mE

🤖 International consensus defines the core elements of GI robotic surgery training:
▪️ Knowledge requirements
▪️ Structured curriculum
▪️ Performance assessment
▪️ Certification standards
➡️ Supporting safer and more standardized robotic surgical education worldwide.

Work by Michael G Fadel , Josephine Walshaw , Marina Yiasemidou , Matthew Boal , Francesca Pecchini , Muhammed Elhadi , Lisa H Massey , Francesco M Carrano , Matyas Fehervari , Caoimhe M Walsh , Piers R Boshier , Jennifer Eckhoff , Peter Buckle , the European Robotic Surgery Consensus (ERSC) Study Group , Suzanne S Gisbertz , Nicole Bouvy , Alberto Arezzo , Silvana Perretta , Felix Nickel , Jim Khan , George B Hanna , Barbara Seeliger , Stavros A Antoniou , Hans F Fuchs , Nader K Francis , Christos Kontovounisios

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Analysis of Short-Term Outcomes in #PancreaticSurgery with #VascularResection from a Prospective Multicenter Global Study

https://t.co/yzJldSDdRE

@ZhiVenFongMD
@SyedAAhmad5

[Annals of Surgery @AnnalsofSurgery]

Among patients with clinically staged T1 ampullary cancer, more than two-thirds were upstaged to a higher pathologic T stage and nearly half were found to have nodal disease at resection. https://t.co/0UguL9dpiA

[BJS Open @BjsOpen]

Preoperative biliary drainage in perihilar cholangiocarcinoma: retrospective multicentre analysis
➡️https://t.co/sFVF7CTWxX

This retrospective multicentre cohort study evaluated the impact of preoperative biliary drainage on postoperative outcomes in patients undergoing resection with curative intent for perihilar cholangiocarcinoma. Leveraging data from 27 international high-volume hepatobiliary centres, and using both propensity score weighting and multivariable regression, it was demonstrated that preoperative biliary drainage is associated with a significantly higher risk of posthepatectomy liver failure. These findings question the routine use of biliary drainage and support further prospective evaluation of drainage-free surgical strategies in selected patients.

👏👏👏Julien A Luyten , Pim B Olthof , Sander M J van Kuijk , Silvio Nadalin , Hauke Lang , Ruslan Alikhanov , Joris I Erdmann , Johann Pratschke , Shishir K Maithel , Roberto Troisi , Andreas A Schnitzbauer , Ernesto Sparrelid , Peter Lodge , Massimo Malagò , Ulf P Neumann , Erik Schadde , Hassan Z Malik , Keith J Roberts , Baki Topal , Frederik J H Hoogwater , Jeroen Hagendoorn , Andrea Ruzzenente , Concepcion Gomez , William R Jarnagin , Matteo Cescon , Luca Aldrighetti , Bas Groot Koerkamp , Maxime J L Dewulf , Steven W M Olde Damink on behalf of the , Perihilar Cholangiocarcinoma Collaboration Group
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery

[IHPBA @IHPBA]

Giuseppe et al. 89.4% textbook outcome rate in 546 robotic liver resections at high-volume US centre surpassing rates reported for open & laparoscopic approaches. Supports robotic surgery as valuable tool for complex liver resection in experienced hands 🔗https://t.co/78ALxqxj8K

[Syed A. Ahmad @SyedAAhmad5]

Clinical and molecular landscape of surgically resected early onset pancreatic cancer @bjs https://t.co/ksZudOMDCN

[JAMA Surgery @JAMASurgery]

Surgical therapy for #gastroparesis in adults with #diabetes was associated with improved glycemic control, reduced insulin utilization, and fewer diabetes-related complications vs nonoperative management.

https://t.co/KbqTLc15vH

[Annals of Surgery @AnnalsofSurgery]

Among patients undergoing hepatopancreatic cancer surgery, textbook outcomes were modestly more common among early- and middle-career surgeons who completed dedicated HPB fellowships. https://t.co/0QTOsMvzSC

[Omero P Costa Filho @omerofilho]

Outcomes of Y90-radioembolization as downstaging to liver... : Hepatology https://t.co/gHmm7eSlBa

[Arndt Vogel @ArndtVogel]

Outcomes of Y90-radioembolization as downstaging to liver transplantation HCC and tumoral portal vein thrombosis
@HEP_Journal
https://t.co/RcHl1K7vxQ
👉25% sustained downstaging after TARE
👉15% eventually LTx with good outcome
🧐Downstaging is feasible in MVI pts
@myESMO @ILCAnews @EASLnews

[Syed A. Ahmad @SyedAAhmad5]

Practice Patterns of Graduates from a Surgical Oncology Fellowship Program @annsurgoncol https://t.co/VSrmnLW5Qw

[AmJSurgery @AmJSurgery]

Implementation of robotic pancreaticoduodenectomy at a community tertiary care hospital utilizing a comprehensive curriculum 🔪 @herbchen @pferrada1 @PipeCabreraV @CiruAndes2 @SWexner @TomVargheseJr @sminaev2015 Link: https://t.co/j9nYZWQ415

[JAMA Surgery @JAMASurgery]

DUPAN-2 was an effective surrogate biomarker for monitoring treatment response in patients with #PancreaticCancer who are carbohydrate antigen 19-9 nonexpressors, and normal levels were associated with improved outcomes. https://t.co/HWjLmXIbqU

[Arndt Vogel @ArndtVogel]

Adjuvant hepatic arterial infusion pump CTx with floxuridine for resectable CRC metastases and a low clinical risk score: A randomized controlled trial—The PUMP trial.
#ASCO26
👉mPFS 15 vs 15.5 mo
👉similar 5-yr OS rate
🧐no benefit for HAIP...
@myesmo @ASCO

[Samuel Hume @DrSamuelBHume]

One of the most amazing things I’ve ever seen: a standing ovation for the full Daraxonrasib results

I feel inspired and energised, to put it mildly — we have a targeted therapy for pancreatic cancer now, and nothing is undruggable anymore

[NEJM @NEJM]

Presented at #ASCO26:

Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq

@ASCO

[Annals of Surgical Oncology @AnnSurgOncol]

May Issue: Evaluating the Influence of a #RiskCalculator on Physician Risk Perception and Decision-Making in IPMN Surveillance: A Randomized Trial

https://t.co/dnNlo0MTlt

@DrSabha
@SyedAAhmad5
@SocSurgOnc

[Annals of Surgery @AnnalsofSurgery]

Whole-mount digital large-section pathology identified substantially more positive liver margins after resection of perihilar cholangiocarcinoma than conventional sectioning methods. https://t.co/ovXBmYm1XV

[Annals of Surgery @AnnalsofSurgery]

A computer vision algorithm using preoperative CT scans demonstrated comparable performance to expert radiologists and surgeons in predicting SMA margin status after Whipple for pancreatic ductal adenocarcinoma. https://t.co/eW5JQixYLh

[Omero P Costa Filho @omerofilho]

Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions https://t.co/A2EYngNQHI